Abstract
Negative-pressure wound therapy (NPWT) is being increasingly used in the management of different types of wounds over the last few decades. It relies on generating a negative pressure on the surface of the wound, which is believed to promote wound healing. Although NPWT is used for various types of chronic wounds, acute wounds, and surgical incisions, not all types of wounds may benefit from NPWT. A thorough understanding of the principles of NPWT is crucial for its appropriate use. This chapter reviews the basic concepts of NPWT and the current evidence in support of its use in various surgical fields, especially orthopedic trauma, total joint arthroplasty (TJA), and orthopedic oncology. NPWT is widely used in trauma patients especially when there are large soft-tissue defects precluding primary closure. The NPWT is also used as prophylactic dressing after hip and knee arthroplasty in high-risk patients. However, well-conducted trials are needed in the future to give definitive answers regarding the clinical superiority of NPWT over the conventional less expensive dressings.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
1 Introduction
A wound is defined as a disruption of the anatomical structure and function of an organ, such as the skin, resulting from a pathologic process beginning internal or external to the organ [1]. Acute wounds are those that repair themselves or can be repaired in an orderly and timely process, while chronic wounds heal in a delayed fashion (often >1 month) [1]. Skin acts as a protective barrier, and irrespective of the type and etiology of the wound, restoration of this normal barrier is important to prevent loss of body fluids, infection, and injuries to underlying tissues and organs. Dressings have been traditionally used to cover and prevent contamination of wounds [2]. However, with the increasing nature of wound complexities and the various local and systemic factors that affect wound healing, advancements in the types of wound dressings have been made, which can promote wound healing in addition to preventing contamination.
Negative-pressure wound therapy (NPWT) has become an integral part in the management of different types of wounds over the last few decades. It relies on creating a subatmospheric pressure on the surface of wound which is believed to promote wound healing, especially when there are various factors which can affect wound healing [3]. The negative pressure is typically applied until granulation tissue develops or until the local conditions are favorable for an additional surgical procedure, such as skin grafting. Negative-pressure wound therapy can be used for chronic wounds, acute wounds, and even surgical wounds (incisional NPWT) [4, 5]. However, not all types of wounds may benefit from NPWT, and studies have shown mixed results regarding the added clinical benefits of NPWT [6]. A thorough understanding of the mechanisms, indications, and applications of NPWT is crucial to promote the judicious use of NPWT. In this chapter, we focus on the principles of NPWT, and discuss the current evidence in support of its use in various surgical fields, especially orthopedic surgery.
2 History
Approximation of the skin edges and obliteration of dead space have long been recognized as crucial components of wound healing. Use of negative pressure was initially implemented in the 1950s to drain the collection of fluid under the skin associated with certain types of surgeries [7, 8]. These devices were composed of subcutaneously placed drains connected to a vacuum device to drain the excess fluid collection, and were reported to prevent fluid collection formation and promote granulation tissue growth [9]. By the late 1980s, scientists in Europe started to apply negative pressure over the surface of wounds with the use of foam and suction tubing [2, 10]. In the 1990s, a series of basic science and clinical studies performed by Argenta [11] and Morykwas [3], highlighting the positive effects of wound deformation, tissue pressure changes, and cytokine stimulation, led to the widespread implementation of NPWT in the present form in the United States. The first commercially available device that provided NWPT was the vacuum-assisted wound closure device and technology (V.A.C.®) (Kinetic Concepts Inc. (KCI), San Antonio, Texas). While the initial application of NPWT was restricted to large open wounds in debilitated patients, the use of NPWT has expanded to include wounds of varying severities and even as a prophylactic measure over surgical incisions. Although a number of negative-pressure device systems have been described, the most popular and widespread clinically used systems consist of delivery of an open-pore foam dressing, which results in the formation of small, domelike structures at the wound surface called microdeformation [12]. Therefore, some authors have suggested the term microdeformation wound therapy (MDWT) to distinguish the commonly used NPWT system from other systems delivering negative pressure [12]. However, in this chapter we use the term NPWT to refer to the commonly used systems that use foam.
3 Mechanism of Action
Although a number of theories have been described, the effects of NPWT can be broadly explained by two basic theories [13, 14]. The first one is based on the mechanical stain imposed on the tissues at the macroscopic and microscopic level, which leads to approximation of the skin edges and stimulation of growth of granulation tissue. The second is based on the removal of excess fluid, inflammatory markers, and potentially bacteria from the wound and the surrounding tissues. However, this last one is controversial and is discussed further in this chapter. Apart from these two mechanisms, the application of NPWT on wound beds has many indirect effects on wound healing, like modulation of inflammation, angiogenesis, peripheral nerve response, hemostasis, improved lymphatic clearance, and alteration in bioburden [12, 15,16,17]. However, the clinical relevance of some of these observed effects is unclear [18, 19].
With the application of the negative pressure, the porous foam shrinks in size and exerts strain on the wound bed, which leads to macro- and microdeformation of the wound (Fig. 1) [12]. Macrodeformation refers to the shrinkage of the size of the wound with the application of the NPWT. The foam used in NPWT systems can reduce in size by approximately 80%, and has been shown to result in a substantial decrease in wound sizes [13]. The extent of the contraction depends on the deformability of the tissue being used with larger shrinkage seen with abdominal wounds, compared to less deformable tissues located in the extremities or in a previously irradiated tissue bed [20]. Additionally, the wound contraction is associated with a paradoxical rise in the pressure of the surrounding tissues presumably due to the tension applied on the tissues by the contracting wound [12]. This can decrease the blood supply and can be detrimental in certain types of wounds, especially in ischemic limbs if circumferential NPWT is administered. In addition to the changes at the macroscopic level, the porous surface of the foam results in an undulated wound surface at a microscopic level [21]. This microdeformation results in strain of the tissue’s cytoskeleton, which in turn stimulates cell proliferation, migration, and differentiation [22]. These microscopic changes in the surface of the wound result in faster granulation tissue formation and quicker wound healing [13].
The negative pressure applied over the wounds results in the removal of fluids and clears the wound of toxins and exudates. Removal of fluid relieves the compressive effect of extracellular fluid on surrounding tissues and has been shown to improve circulation in the wound bed [23]. Removal of fluid also reduces the amount of fluid that must be cleared by the lymphatics and induces a local increase in lymphatic density [24]. It is also important to understand that the basic science evidence behind incisional NPWT (application over a primarily closed wound) has also been shown to afford similar benefits as application over open wounds, such as decreased tension on the skin, improved blood flow in the dermal location, and decreased seroma/lymphedema formation [17]. The use of NPWT does not appear to reduce the bacterial burden in the wounds. Some studies have even reported that the use of NPWT can increase the bacterial burden although there was enhanced wound healing with NPWT [18, 19].
4 Application of NPWT
NPWT does not replace the basic principles of wound management. Wounds should be thoroughly debrided, and necrotic or infected tissue should be removed prior to the application of NPWT. There are five basic components to the modern-day NPWT system, including wound filler, tubing, drapes, a pump, and a canister. The most commonly used wound filler is open-cell polyurethane foam and is composed of interconnected cells of size ranging between 400 and 600 μm in diameter [15]. The porous nature of the foam allows the pressure to be evenly distributed throughout its entire surface. Once the wound bed is ready, the foam piece is cut into an appropriate size so that the foam stays within the wound edges. After the application of the foam, a semiocclusive adhesive drape is placed over the wound covering the entire foam to ensure an airtight seal. The drape should have at least 3–5 cm of border to ensure maintenance of a tight seal. A small hole is made in the drape and a non-collapsible tube is placed over the hole and connected to a vacuum pump. The fluid drained from the wound is collected in the canister attached to the pump. The pressure applied by the pump can vary depending on the local wound conditions, and the device can be programmed to provide both continuous and intermittent negative pressure. The standard suction pressure is 125 mmHg, as optimal granulation tissue formation has been reported with this pressure [25]. However, other pressures have been reported depending on the size of the wound, location, and predisposition to bleeding. The most common mode of negative-pressure application is the continuous mode, but intermittent suction (for periods of 5 min separated by 2-min intervals) may be associated with greater stimulation of granulation tissue formation [3, 26]. However, intermittent therapy is not routinely used, as sudden and frequent changes in pressure can create varying discomfort for patients. Despite this, it is recommended to advance from continuous suction to intermittent suction in acute wounds, after the initial 48 h, unless there is uncontrolled pain, suction leaks, or an uneven wound surface. The duration of use of NPWT depends on the type of wound and the treatment goals. Chronic wounds often require prolonged treatment with NPWT, sometimes over a period of months, and NPWT might be continued until satisfactory outcomes are obtained. The negative-pressure dressing should be changed once every 48–72 h to prevent fluid saturation of the foam, which can decrease the effectiveness of the treatment. Newer dressings, however, such as the incisional NPWT dressing, can be placed over closed wounds for up to 7 days without changing. For infected wounds, dressings may need to be changed more frequently, though the clinician should be cautious about the use of these dressings over grossly infected wounds.
5 Advancements in NPWT
Since the initial introduction of V.A.C.® in the 1990s, significant advances have been made in the field of NPWT to cope with the expanding indications. One major challenge of the NPWT therapy is the maintenance of a tight seal so the negative pressure can be delivered. Automated alarm systems are currently available which can detect inadequate seal. Additionally these electronic systems can detect excessive fluid output and can be programmed to deliver negative pressure at various intervals. Two major advancements in the field of NPWT have been the availability of incisional NPWT and negative pressure with instillation.
Surgical wounds are closed with either sutures or staples and heal by primary intention. Surgical incisions from trauma-related surgery, total joint arthroplasty, cardiothoracic surgery, vascular surgery repair in the setting of known ischemia, major soft-tissue rearrangement plastic surgery interventions, and neurosurgical procedures are at high risk of wound dehiscence and increased risk of surgical site infections, all being studied in the setting of these recent advancements of NPWT. Traditionally, negative pressure has been used to treat complex open wounds, which usually heal by secondary intention. However, with the increasing popularity of NPWT, the indications for NPWT have extended as a prophylactic measure in the management of closed surgical incisions (incisional NPWT). Currently, there are commercially available NPWT dressings that can be applied over surgical wounds, such as Prevena™ (KCI, San Antonio, Texas) and PICO (Smith and Nephew, St. Petersburg, Florida) [27]. Compared to the traditional NPWT devices, Prevena and PICO are composed of lightweight portable suction devices that allow patients to remain ambulatory with the dressing. The PICO system is different in that it does not have a canister and the fluid is lost by evaporation [28]. In a meta-analysis by Hyldig et al. [29], NPWT significantly reduced the rate of wound infection and seroma when applied to closed surgical wounds compared with the standard postoperative dressings. However, there was heterogeneity between the included studies, meaning that no general recommendations could be made. Also, they reported that a relatively large number of patients were lost to follow-up in the control groups and length of follow-up might have been inadequate to detect surgical site infections [29]. Although, conclusive evidence regarding the benefit of incisional NPWT is lacking, it is believed that they may be beneficial for surgeries in high-risk patients such as those with medical histories characterized by diabetes, obesity, active smoking status, an immunocompromised state, active dialysis, or previously irradiated wounds.
Maintaining a moist wound environment facilitates the wound healing process by prevention of tissue dehydration and cell death, accelerated angiogenesis, and increased breakdown of dead tissue and fibrin. Negative-pressure wound therapy with instillation has recently been introduced in various settings. This technology combines the traditional negative-pressure system with a method to intermittently instill a solution into the wound [30]. In addition to keeping the wound bed moist, it also enables the controlled delivery of topical anesthetic and antiseptic solutions over the wound bed. First, the instillation fluid drips by gravity through a tube to saturate the foam and then the fluid is allowed to bathe the wound for a predetermined period of time (from 1 s to 1 h). Then, the vacuum is applied through a separate (suction) tubing (5 min to 12 h), thereby removing the irrigation fluid and wound exudate and collapsing the sponge. Suction is continuously maintained until the entire cycle is repeated according to the amount of time programmed into the unit. The instillation solutions include normal saline, bacitracin, povidone-iodine, polyhexanide, acetic acid, antifungals, antiseptics, silver nitrate, local anesthetics, and insulin, depending on the type of wound and desired effects [30, 31]. Alcohol-based solutions and solutions that contain alcohol are contraindicated for use with NPWT with instillation as alcohol is not compatible with wound tissue [32, 33]. Hydrogen peroxide solutions are also contraindicated with this system due to the effervescent nature of this solution [30, 32]. The NPWT dressing is a closed system and any effervescence produced by the hydrogen peroxide may lead to air emboli. In addition, hydrogen peroxide is considered highly cytotoxic and deleterious to wound healing [34]. In a study by Gabriel et al. [35], patients with complex infected wounds treated with instillation of silver nitrate and negative pressure had significantly fewer days of treatment and experienced earlier wound healing compared with the control group. In a retrospective study by Timmers et al. [36], patients with osteomyelitis of the pelvis or lower extremities who received instillation NPWT using polyhexanide had a significantly lower rate of infections compared to patients who were treated with gentamicin-impregnated beads only. As contaminated traumatic wounds are at a high risk for infection, NPWT with antimicrobial instillation may potentially be useful in those cases. Strong evidence supporting the prophylactic use of antimicrobial solutions in contaminated wounds, however, is lacking. In a large multicenter randomized clinical trial (RCT) comparing irrigation protocols of open fractures, irrigation with normal saline resulted in lower rates of infection than castile soap solution [37]. In another RCT by Anglen et al. [38], bacitracin solutions did not decrease wound infection rates compared with normal saline irrigation in decreasing wound infection after open fractures, though wound healing problems were higher in bacitracin-treated patients. Most of the scientific evidences supporting antimicrobial use with or without NPWT have been based on observational cohorts without a control group or based on poorly designed trials. However, in view of the >40% infection rate of contaminated traumatic wounds, NPWT with instillation is expected to be beneficial without any clinically relevant adverse effects [31]. Further prospective randomized studies are needed to clarify this issue.
6 Current Evidence
Although the indications for NPWT have rapidly expanded, there is a paucity of high-level evidence supporting the use of NPWT [39]. While NPWT has proven to be beneficial for certain types of wounds like diabetic wounds, sternal, and abdominal wounds, the benefits are unclear for vascular wounds and surgical wounds [4]. A large number of studies including RCTs and meta-analyses of RCTs have been published in this field and have provided mixed results partly owing to the heterogeneity in terms of wound types, outcome variables, and outcome assessments [40]. Conflict of interest in NPWT-related research is also a matter of concern as most studies were sponsored by the two main device manufacturers [15, 29]. Additionally, a number of RCTs studying the effects of NPWT were not published and the lack of access to unpublished study result data raises doubts about the accuracy of the available evidence [41]. Further, we focus on the current evidence in support of the use of NPWT in orthopedic trauma, total joint arthroplasty (TJA), and orthopedic oncology (Table 1). Additionally, the use of NPWT in other fields is also briefly reviewed.
6.1 Orthopedic Trauma
Since its introduction more than two decades ago, NPWT has had an important impact in orthopedic trauma. The use of NPWT has been adopted in a variety of clinical scenarios in orthopedic trauma, which includes extensive soft-tissue injuries, penetrating trauma, open fractures resulting from high-energy trauma, and fasciotomy incisions. Treatment of traumatic wounds is challenging due to significant wound contamination, need for subsequent debridement, significant edema, or systemic compromising factors from multiple injuries. Negative-pressure wound therapy can be quickly applied and may potentially prevent wound desiccation, minimize microbial contamination, reduce edema, and facilitate wound drainage.
6.1.1 Soft-Tissue Trauma
War wounds pose a challenge to trauma surgeons. These wounds are usually sustained due to energy transfer (gunshots, blasts, and explosives) across multiple tissue planes. These high-energy wounds are heavily contaminated and characterized by extensive loss of soft and/or osseous tissues. Traditionally, these wounds are managed in field hospitals with adequate irrigation and debridement, application of wet-to-dry dressings, and bedside dressing changes. Despite repeated irrigation and debridement of war wounds, wound healing is particularly challenging due to extensive tissue loss, breakdown of traumatized soft tissue, wound necrosis, and infection that requires additional surgical interventions [42]. A systematic approach to war wounds was thus implemented to include eliminating bedside dressing changes and instituting mandatory interval wound examination, re-debridement, and dressing changes in the cleaner environment of an operating room [42]. Negative-pressure wound therapy is advantageous in such settings by keeping the wound covered while simultaneously promoting wound contraction, controlling wound drainage, decreasing wound edema, and augmenting wound granulation and healing [43, 44]. The ease of the application of NPWT is helpful in war injuries as it allows for the temporary coverage of large soft-tissue defects in hospitals located in or near areas of conflict before the patient can be transported to better facilities.
DeFranzo et al. [45] evaluated 75 patients who had open wounds and extensive soft-tissue damage or breakdown, concluding that NPWT decreased tissue edema by diminishing the circumference of the extremity and, thus, decreased the wound surface area allowing for successful wound closure in 71 out of 75 patients. Leininger et al. [46], based in a field hospital, treated 77 patients who sustained a total of 88 high-energy wounds. All wounds were operated on within 24 h of injury, and were covered with NPWT dressings and set to −125 mm Hg continuous pressure for 2–4 days. They reported no acute wound complications, and no reoperations on those who required skin grafts, and all of the patients had clean and closed wounds. In another study by Helgeson et al. [47], 16 patients who had high-energy complex soft tissue with exposed tendon and/or bone that were not amenable to skin graft were initially treated with a bioartificial dermal substitute regeneration template and NPWT. The authors concluded that NPWT had a beneficial effect on the formation of granulation tissue and as a barrier to reduce potential infection.
Stannard et al. [48] randomized 44 patients who suffered injuries from high-energy trauma and developed wound hematomas into two management groups, pressure dressing or NPWT. Dressings were changed daily in the pressure dressing group and every other day in the NPWT group. They found that NPWT was associated with a shorter duration of wound drainage (1.6 vs. 3.1 days, p=0.03) and lower, but not statistically significant, infection rate (8% vs. 16%, p >0.05). Therefore, application of NPWT may offer some advantage in the management of highly complex soft-tissue injuries by promoting wound healing and potentially decreasing incidence of infection.
6.1.2 Open Fracture-Related Wounds
Open fractures are challenging for orthopedic surgeons. High-energy trauma results in not only bone fractures, but also large soft-tissue loss or breakdown. These injuries are at a high risk for infection and osteomyelitis. Open fracture infection rates are reported to range from 16 to 66% depending on the type of fracture, severity of the soft-tissue injury, and patient-related comorbidities [49, 50]. The primary goal of surgical treatment for open fractures is stabilization of the fracture, followed by soft-tissue repair. Careful homeostasis and wound coverage are important for reducing the risk of infection. Traditionally, these wounds undergo a series of irrigations and debridement to ensure that all nonviable tissues are removed to allow for subsequent healing by secondary intention with granulation tissue. Theoretically, NPWT may play an important role in the periods between surgical interventions, where it may be more advantageous than the standard wet-to-dry dressings [51].
In an RCT by Stannard et al. [52], 59 patients who had 63 severe high-energy open fractures were randomized to receive either a standard fine-mesh gauze dressing or a NPWT between irrigation and debridement procedures until definite closure was performed. They found that patients treated with NPWT were less likely to develop an infection compared to the control group (relative risk for infection [RR] = 0.199, 95% confidence interval [CI] 0.05–0.87). Blum et al. [53] retrospectively reviewed 229 open tibia fractures where 72% of patients received NPWT and 28% received a conventional dressing, and found a significantly lower deep infection rate in the NPWT group (8.4% vs. 20.6%, p = 0.01). After adjusting for injury severity, NPWT was found to reduce the risk of deep infection by almost 80% (odds ratio [OR] = 0.22; 95% CI, 0.09–0.55; p = 0.001).
Virani et al. [54]conducted a RCT to study the effect of NPWT on deep infection and osteomyelitis after open tibia fractures, and they reported a significant reduction in the incidence of infection with use of NPWT compared to controls (4.6% vs. 22%; p < 0.05). Wound cultures showed positive growth in 3 patients who received NPWT and 17 in the control group (6.9% vs. 34%; p < 0.05), and the probability for infection in the NPWT group for a wound with an open fracture was 5.5 times less compared to controls. However, there was no significant difference in the time required for the wound to be ready for delayed primary closure or coverage. In another RCT by Arti et al. [55], treatment of open fractures with NPWT resulted in a reduction of wound surface volume and lower hospital length of stay. However, the authors did not find a difference in the infection rates. While there are discrepancies in the results of various RCTs evaluating the efficacy of NPWT, overall NPWT appears to have several benefits in the management of open fractures including lowering infection rate, accelerating closure of open wounds, and shortening the hospital length of stay.
6.1.3 Fasciotomy Wounds
Compartment syndrome is considered a surgical emergency, with the treatment goal being to decrease the muscle compartments pressure while maintaining tissue perfusion, which is achieved by open fasciotomy. Primary closure of these wounds would theoretically result in more functional and aesthetic outcomes with decreased morbidity. However, due to muscular edema, protrusion of muscles through the fascia, and significant skin retraction, premature primary closure may increase the compartmental pressure and the forced re-approximation under tension may cause necrosis at the wound edges. Healing by secondary intention had been a commonly used technique, but due to the increased risk of infection, longer hospitalization, increased requirements of frequent dressing changes, delay in rehabilitation, significant scarring, and poor aesthetic outcome, it is no longer considered an appropriate intervention. Serial dressing changes are often needed until definitive primary closure is possible. Primary coverage with NPWT creates a closed environment, which in theory protects the wound from outside infection, reduces local edema, and reduces the need for frequent dressing changes until final closure is achieved.
A large retrospective study by Zannis et al. [56] evaluated 458 patients who had 804 wounds, and demonstrated a significantly earlier time to primary closure (NPWT vs. standard = 5.2 vs. 6.5 days, p < 0.01) as well as higher rate of primary closure in fasciotomy wounds treated with NPWT compared to standard wet-to-dry dressings. On the other hand, Kakagia et al. [57] in an RCT comparing NPWT with the shoelace technique (gradual suture approximation technique to facilitate wound closure) found no difference in wound infection rates between the groups. They found that the wound closure time was significantly prolonged in the NPWT group compared to the shoelace method group, and the cost of treatment was also increased in the NPWT group. Although NPWT has become increasingly popular for the closure of fasciotomy wounds, the efficacy of these dressings to decrease infection and shorten time to closure remains uncertain.
6.1.4 Incisional Wounds
The outcomes of NPWT are promising in the management of surgical incisions and prevention of the development of hematomas in closed wounds.
Stannard et al. [48] evaluated NPWT as an adjunct to healing of surgical incisions after fractures that were at high risk for wound complications in terms of wound drainage. They showed that NPWT was associated with a significant reduction in the duration of wound drainage (1.8 vs. 4.8 days; p = 0.02). They also showed similar results in a larger randomized controlled trial where they prospectively evaluated the role of NPWT for the prevention of wound dehiscence and infection after high-risk lower extremity trauma in 249 patients who had 263 fractures [58]. In this study, incisional NPWT was applied to the closed surgical incisions in 141 patients, whereas standard postoperative dressings were applied to 122 control patients. The infection rate was significantly lower in the NPWT group compared to the control group (9.7% vs. 18.9%; p = 0.049). Similar results were also reported in an RCT by Nordmeyer et al. [59] who compared NPWT to standard dressing after dorsal stabilization of spinal fractures in 20 patients (10 in each group). The NPWT reduced the development of postoperative seromas, nursing time, and material required for wound care. Overall, the use of NPWT appears to be beneficial in the management of surgical incisions in the trauma setting following fixation of high-risk fractures. Negative-pressure wound therapy has been reported to reduce wound drainage, postoperative infection, development of seromas/hematomas, and time and costs related to wound care [60].
6.2 Total Joint Arthroplasty
Total joint arthroplasty (TJA) is a common procedure with approximately one million total knee arthroplasties (TKA) or total hip arthroplasties (THA) being performed annually in the United States [61]. Periprosthetic joint infection (PJI) is a serious complication of TJA with the incidence reported to be from 1 to 2% [62]. The incidence of PJI is even higher after revision surgeries, and can be up to 20% [63]. Approximately 25% of PJIs occur within the first month following the surgery and these early infections are usually associated with wound complications like drainage and wound dehiscence [64]. It has been reported that each day of prolonged wound drainage can increase the risk of wound infection by 42% following THA and by 29% following TKA [65]. Therefore, over the past decade, there has been increased attention placed on NPWT as an effective technique to help prevent wound complications following TJA.
The predominant use of NPWT in arthroplasty is in the form of incisional NPWT dressings. Although a number of observational studies have described the utility of negative-pressure dressings on surgical incisions following TJA, the results of different studies on this topic are inconclusive. In an RCT by Howell et al. [66], no benefits were observed with the use of incisional NPWT in TKA patients at high risk for prolonged wound drainage. However, a higher incidence of blister formation was observed in the NPWT group leading to premature cessation of the trial. But, later RCTs have shown some beneficial effects with the use of incisional NPWTs. In a study by Pachowsy et al. [67], the authors randomized 19 patients undergoing primary THA for osteoarthritis into either a group receiving standard wound dressing or a group receiving NPWT, and showed decreased volume of postoperative seromas on day 10 in the NPWT group (NPWT vs. standard: 1.97 mL vs. 5.08 mL, p = 0.021). Although reduction of postoperative seromas can theoretically lead to increased blood flow, better apposition of the wound edges, and decreased risk of drainage, there is currently no evidence to suggest that reduced seroma can decrease rates of clinically relevant complications such as PJI [60, 67]. The use of incisional NPWT has also been reported to decrease wound dressing changes and to eliminate excessive hospital stay following primary TJA [28, 60]. In an RCT of 220 patients undergoing primary TKA/THA, Karlakki et al. [28] found that the use of incisional NPWT decreased the amount of wound drainage and eliminated prolonged length of stay. In another RCT by Manoharan et al. [68] the use of incisional NPWT following primary TKA was associated with improvement in wound leakage and better wound protection, although no benefit was found with respect to hospital cost and wound healing.
Although studies have shown that the use of incisional NPWT can decrease wound exudates, decrease in wound infection after primary TJA has not been reported with the use of NPWT. This might be due to the fact that the incidence of PJI is very low compared to the incidence of other wound complications like wound drainage. In an RCT by Gillespie et al. [69], the authors did not find a decrease in surgical site infections with the use of NPWT in patients undergoing primary THA. Furthermore, they suggested that a definitive trial would require approximately 900 patients per group to demonstrate a decrease in SSI after primary arthroplasty. Even though current evidence suggests that wound complications place patients at a higher risk for the development of PJI, there is uncertainty around the benefits of NPWT following elective arthroplasty for decreasing the infection rate [69]. The reasons for the differences in the results of various RCTs are probably related to the heterogeneity of the patient population in terms of the type of arthroplasty (primary or revision) and the indication for arthroplasty (fracture or osteoarthritis) [60, 70]. Although NPWT may not have an added clinical advantage over the standard occlusive dressing in primary elective arthroplasty, it might be helpful in certain high-risk populations like patients who undergo revision arthroplasty. For example, the findings of a comparative study by Cooper et al. [70] suggest that incisional NPWT may decrease wound complications and SSIs in patients who undergo revision hip and knee surgery. The benefits of NPWT may be even more apparent after revision surgery for PJI or in patients with preexisting wound issues. While strong evidence to support the prophylactic use of NPWT in primary or revision arthroplasty is lacking, there are a number of ongoing clinical trials, which might help to better understand the indications for incisional NPWT in TJA.
In addition to the use of incisional NPWT as a prophylactic measure, NPWT can also be used to treat chronically infected, dehisced, or draining wounds in the setting of knee or hip arthroplasty (Fig. 2). In a retrospective study of 109 patients who had persistent drainage after primary THA, Hansen et al. [71] showed that majority of the patients (76%) had cessation of the drainage after being treated with NPWT. Therefore, NPWT can potentially avert morbid surgical procedures which are traditionally performed for persistent drainage. Hansen et al. [71] also demonstrated that patients who failed NPWT therapy and required a subsequent surgical procedure had success rates similar to the published literature, indicating that NPWT might be safely considered as a first-line treatment modality for persistent drainage [72]. Treatment of PJI involves extensive debridement of soft tissues, which can often compromise the soft-tissue coverage required for primary closure, especially for the knee. Therefore, NPWT can be used in such instances to promote granulation tissue formation and to act as a bridge until definite closure can be performed. The benefits and mechanism of action of NPWT dressing in such settings are similar to other open wounds. The availability of instillation therapy offers the additional advantage of providing topical antimicrobial solutions, which may help in the clearance of infections, although the benefits of this remain unclear [73]. Even though NPWT dressing is widely used to treat wound drainage and other wound-related complications after arthroplasty, the majority of studies describing the use of NPWT to treat wound-related complications were performed without a control group. Therefore, the clinical superiority of NPWT over the traditional dressings in terms of faster wound healing and improved infection clearance has not been established. It is reasonable, however, to assume that NPWT can at least decrease the number of wound dressing changes in actively draining wounds, and can remove some tension on the wound edges, and keep them better approximated under lower stress.
6.3 Orthopedic Oncology
Bone and soft-tissue sarcomas are relatively uncommon cancers, but over the past decade, the estimated incidence increased from 12,000 to 15,000 new cases per year [74, 75], with the most common soft-tissue sarcomas occurring on the extremities [76]. Historically, the treatment for sarcomas of the extremities was limb amputation; however, there was a shift towards limb salvage procedures with adjuvant chemotherapy and/or radiotherapy [77,78,79], which has been associated with more patient satisfaction [80], improved physical function [81], and less disability [82]. Limb salvage procedures involve wide surgical margin resection, sometimes necessitating soft-tissue defect, bone defect, or vascular reconstruction in order to minimize recurrence risk and maximize long-term limb function [83,84,85,86]. Particularly with soft-tissue sarcoma, wide excision, in combination with neoadjuvant or adjuvant radiotherapy, has been shown to have positive effect in time to local recurrence and overall survival [87]. Despite the benefits of limb salvage procedures, tumor resection and radiotherapy can lead to significant wound complications, which can be a cause of significant morbidity [88]. Surgical resection of bone and soft-tissue sarcomas is often difficult due to involvement of the adjacent fascia and neurovascular structures [77], and depending on the location of the tumor and the surrounding tissues involved, patients may have large open wounds with soft-tissue defects [89]. Despite the benefits conveyed regarding local recurrence, radiotherapy also is strongly associated with various wound-related complications, with a higher rate of wound complications (~30–40%) with neoadjuvant radiation as compared to adjuvant therapy (~20–25%). One study reported on 202 patients who had preoperative radiotherapy and then had surgery for soft-tissue sarcoma of the lower extremity (n = 119), upper extremity (n = 32), trunk (n = 36), and head and neck (n = 15) [90]. The overall wound complication rate was 37%, and a second surgery for the wound complications was required in 16.5%. Similarly, Kunisada et al. [91] evaluated 43 patients who underwent preoperative radiotherapy followed by surgery for soft-tissue sarcomas of the lower leg (n = 28), upper arm (n = 8), and trunk (n = 7). They reported a high complication rate, with preoperative radiotherapy-associated acute skin toxicity that occurred in 84% of cases, and a postoperative wound complication rate of 44%, of which 23% required an additional surgery.
Resection of large bone or soft-tissue tumors can lead to massive soft-tissue defects that cannot be closed at the time of surgery. Bickels et al. [92] reported on 62 patients who underwent resections of either bone or soft-tissue tumors and were left with a large soft-tissue wound defect after surgery, debridement from wound complications, or radiation-associated skin necrosis. Twenty-three of these patients had a NPWT device placed for a mean of 14 days (range 7–19 days), and were followed for a median of 19 months (range 12–27 months). Their outcomes were compared to a similar cohort of 39 patients who were treated prior to the surgeon’s use of NPWT. Compared to historical controls, the patients who were treated with the NPWT had a decreased rate of additional surgical wound procedures and a higher rate of primary wound closure, and had shorter hospital length of stay. The soft-tissue defect area decreased by a mean of 25% in those who received NPWT.
In those patients with large soft-tissue defects from resection of bone and soft-tissue tumors, incisional NPWT allows for improved healing and primary wound closure [89]. In addition to the use of negative-pressure dressings, silver has been added to the dressings in order to prevent surgical site infections [93]. Siegel et al. [93] reported on 42 patients who suffered from massive soft-tissue loss resulting in large extremity and/or pelvic wounds and compared a plain NPWT dressing to a NPWT with silver dressing. Tumors were the etiology in 14 of the patients; 11 patients underwent local radiation and 12 patients had immunosuppression either from chemotherapy or from a transplant. The etiology in the remaining patients was infections in 22 and trauma in 6 patients. The patients who had the NPWT with silver dressing had a decreased length of stay compared to the patients with the NPWT alone (7 vs. 19 days, p < 0.033). Compared to the patients who only had the NPWT, the NPWT plus silver dressing patients had to undergo fewer surgeries prior to flap coverage (62% vs. 19%, p = 0.024) and had required fewer surgical debridements (7.9 vs. 4.1, p < 0.001). It seems that the addition of silver to NPWT dressings may have a positive effect for wound healing in such patients. Additional studies are needed to have definitive conclusions.
6.4 Other Major Indications
Perhaps, one of the first indications of NPWT was the treatment of chronic wounds. Chronic wounds pose a great challenge to the medical community, and with the increasing prevalence of bed-ridden patients and those with chronic conditions such as diabetes mellitus and peripheral vascular disease, more patients are being diagnosed with chronic wounds. These wounds are difficult to heal, and may be due to the continuous exposure to the external environment, which can result in colonization with bacteria and fungus. Negative-pressure wound therapy, though, has revolutionized the management of chronic wounds. The primary goals of NPWT in chronic wounds are to achieve wound closure (by surgical or secondary intention), reduce the wound size, improve patient quality of life, manage wound fluid and edema, and prevent wound deterioration. However, the effectiveness of NPWT in achieving these goals depends on the type of wound. Currently there is strong evidence to support the use of NPWT in diabetic foot ulcers. In a multicenter RCT, Armstrong et al. [94] reported that treatment of diabetic foot wounds with NPWT led to a higher proportion of healed wounds, faster healing rates, and potentially fewer re-amputations than standard care. In another multicenter RCT, a greater proportion of foot ulcers achieved complete ulcer closure with NPWT, suggesting that NPWT is more effective than the standard dressings [95]. There is a moderate amount of evidence supporting the use of NPWT in pressure sores and venous stasis ulcers. In an RCT by Vuerstaek et al. [96], the use of NPWT was associated with faster wound healing of venous ulcers and resulted in lower costs. Although a few RCTs have suggested some benefits with the use of NPWT in pressure ulcers, the overall quality of evidence is low and the clinical effectiveness of NPWT is inconclusive [97]. There appears to be no benefit with NPWT in the setting of chronic ischemia ulcers [4]. The benefits of NPWT are usually seen in large edematous wounds, while the wounds arising in the setting of arterial insufficiency are usually in the toes, without much swelling unless there is an associated infection [98]. Additionally, as most of the wounds related to arterial insufficiency are small and surrounded by nonviable tissue, surgical debridement might be preferred over NPWT, which may explain why the literature on the treatment of vascular ulcers is limited [99]. The use of NPWT in an acutely ischemic leg may even have detrimental effects as excessive negative pressure may further compromise blood flow [4].
In addition to major orthopedic indications for NPWT, other areas of application that have been studied include open abdominal wounds, sternal wounds, and skin graft host environments [4, 100,101,102]. While not the scope of this book chapter, these large defects and scenarios can mimic many of the situations in orthopedic surgery and add important insight into the applications for NPWT in the treatment of major appendicular and axial wound concerns.
7 Adverse Events
There have been few complications associated with NPWT, and they can often be avoided or minimized with proper application. The most common complications of NPWT are skin related, which can range from a simple rash to a large blister. Blister formation is an important adverse effect with the use of incisional NPWT due to the direct application of negative pressure over the normal skin. In an RCT by Howell et al. [66] the study was prematurely interrupted when a total of 60 patients were enrolled and a significant difference in blister formation about the knee was detected between the NPWT group and the control group. In order to address the issue of blistering, a non-adherent dressing has been recommended for use over unprotected skin to avoid direct contact with the foam [15, 66]. The study by Howell et al. [66] was one of the initial studies that used an incisional NPWT dressing and blistering was not found to be an issue in the subsequent studies, where the normal skin was protected [103]. Allergy to the components of the NPWT dressing (e.g., adhesive or silver) can also cause skin rashes. The skin of patients who have been treated with immunosuppressive drugs may be fragile and more prone to desiccation from the use of negative pressure [104, 105].
If the sponge is left deep in a wound for prolonged periods (more than 48 h), it can be difficult to extract because of the overgrowth of exuberant granulations. Extraction of the sponge may be associated with minor bleeding due to the highly vascular granulation tissue. To prevent the ingrowth of granulation tissue, dressings are recommended to be changed every 48–72 h. Since this is not an issue with incisional dressings, NPWT can be kept over wounds for longer periods (7 days or longer). Although NPWT is used in tumor surgeries to help with wound closure and prevent wound complications, the effects of negative pressure on neoplasms are unknown. As NPWT is known to stimulate the cytoskeleton and promote granulation tissue, it is thought to maybe have stimulatory effects on the neoplasm as well. Therefore, NPWT is contraindicated for use over neoplastic wounds. However, NPWT may be used for wound closure after resection of deep or superficial tumors. Patients on anticoagulants and those with a history of a bleeding disorder may develop hematomas from the application of negative pressure, especially when wounds are large, and these patients need to be monitored. Lower levels of negative pressure can be used in such cases. When NPWT is used in deep and tunneling wounds, care should be taken to remove the entire piece of foam from the wounds when dressing changes are performed.
8 Cost-Effectiveness
Although the vast majority of the literature supports the efficacy and safety of NPWT, it is important to know whether NPWT is cost effective compared to conventional dressings. A number of studies have suggested NPWT to be a cost-effective method and most insurance companies cover the commercially available NPWT devices. In a study of more than 1000 patients with advanced-stage pressure ulcers, Philbeck et al. [106] demonstrated that wounds treated with NPWT healed faster (97 vs. 247 days) and at a lower cost ($14,546 vs. $23,465) compared to the traditional dressings, suggesting that NPWT is cost effective. However, the cost-effectiveness of NPWT is not fully established for all of the current uses of NPWT. When NPWT is used as a prophylactic agent on surgical incisions, the cost of NPWT ranges from $15/day to $495/week depending on whether the device is a self-made or a commercially tailored for incisions [107]. Since one of the major reasons for the use of incisional NPWT is to prevent surgical site infections, use of prophylactic NPWT might be cost effective due to high costs associated with infections such as PJI [108]. Since NPWT is changed less frequently than wet-to-dry dressings, NPWT can be less labor intensive for hospital staff and may result in overall reduction of cost [109]. The quality of the current evidence supporting the use of NPWT to prevent infection is low and cost-effective analyses are limited [107]. Nevertheless, NPWT is expected to be cost effective at least in patients with well-established risk factors for infections.
The majority of the negative-pressure dressings applied in North America are commercially available preparations [110]. However, these devices can be expensive and may not be readily available throughout the world. Nguyen et al. [110] demonstrated that standard gauze sealed with an occlusive dressing and connected to wall suction was able to achieve similar outcomes to the commercially available devices, but at a lower cost. Further studies are needed to establish such cost-effectiveness.
Conclusions
Negative-pressure wound therapy continues to gain popularity in various specialties including orthopedic surgery, since the indications for its use have grown dramatically since it was first introduced. While efforts have been made to provide an evidence-based guide for its use, this has been limited by a lack of good-quality evidence. The majority of support for the use of NPWT comes from retrospective studies that either fail to compare it to other wound management techniques or are underpowered with both heterogeneous and small patient populations. The majority of the published literature concludes that NPWT is an effective technique but requires more prospective research to support its use. Currently, NWPT is considered superior to traditional dressings for the management of chronic wounds and pressure ulcers. Additionally, in orthopedic surgery, trauma patients experience the most benefit with the use of NPWT especially when there are large soft-tissue defects precluding primary closure. The NPWT is also used as prophylactic dressing after hip and knee arthroplasty in high-risk patients although this is based on observational data. One of the key problems with research in the field of wound healing is founded in the fact that wounds are very difficult to standardize—varying in size, shape, position, and chronicity. Objective assessments of wound healing are not easy to define and labeling wounds based on arbitrary scales is not evidence based. Furthermore, adequate wound healing relies on multiple local and systemic factors and consequently wounds vary from one another. Although the efficacy of NPWT in wound healing is well established, well-designed randomized controlled trials tailored to a specific patient population characterized by a specific wound environment dilemma are needed to give definitive answers regarding the clinical superiority of NPWT over the conventional less expensive dressings.
References
Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC (1994) Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130:489–493
Miller C (2012) the history of negative pressure wound therapy (NPWT): from “Lip Service”; to the modern vacuum system. J Am Coll Clin Wound Spec 4:61–62
Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W (1997) Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 38:553–562
Vig S, Dowsett C, Berg L, Caravaggi C, Rome P, Birke-Sorensen H, Bruhin A, Chariker M, Depoorter M, Dunn R, Duteille F, Ferreira F, Martínez JM, Grudzien G et al (2011) Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: Steps towards an international consensus. J Tissue Viability 20:S1–18
Robert N (2017) Negative pressure wound therapy in orthopaedic surgery. Orthop Traumatol Surg Res 103:S99–103
Gregor S, Maegele M, Sauerland S, Krahn JF, Peinemann F, Lange S (2008) Negative pressure wound therapy. Arch Surg 143:189–196
Raffl AB (1952) The use of negative pressure under skin flaps after radical mastectomy. Ann Surg 136:1048
Silvis RS, Potter LE, Robinson DW, Hughes WF (1955) The use of continuous suction negative pressure instead of pressure dressing. Ann Surg 142:252–256
Byers RM, Ballantyne AJ, Goepfert H, Guillamondegui OM, Larson DL, Medina J (1982) Clinical effects of closed suction drainage on wound healing in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 108:723–726
Fleischmann W, Strecker W, Bombelli M, Kinzl L (1993) Vacuum sealing as treatment of soft tissue damage in open fractures. Unfallchirurg 96:488–492
Argenta LC, Morykwas MJ (1997) Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg 38:563–576
Huang C, Leavitt T, Bayer LR, Orgill DP (2014) Effect of negative pressure wound therapy on wound healing. Curr Probl Surg 51:301–331
Scherer SS, Pietramaggiori G, Mathews JC, Prsa MJ, Huang S, Orgill DP (2008) The mechanism of action of the vacuum-assisted closure device. Plast Reconstr Surg 122:786–797
Thompson JT, Marks MW (2007) Negative pressure wound therapy. Clin Plast Surg 34:673–684
Siqueira MB, Ramanathan D, Klika AK, Higuera CA, Barsoum WK (2016) Role of negative pressure wound therapy in total hip and knee arthroplasty. World J Orthop 7:30–37
Younan G, Ogawa R, Ramirez M, Helm D, Dastouri P, Orgill DP (2010) Analysis of nerve and neuropeptide patterns in vacuum-assisted closure–treated diabetic murine wounds. Plast Reconstr Surg 126:87–96
Kilpadi DV, Cunningham MR (2011) Evaluation of closed incision management with negative pressure wound therapy (CIM): Hematoma/seroma and involvement of the lymphatic system. Wound Repair Regen 19:588–596
Weed T, Ratliff C, Drake DB (2004) Quantifying bacterial bioburden during negative pressure wound therapy: does the wound VAC enhance bacterial clearance? Ann Plast Surg 52:276-9-80
Mouës CM, Vos MC, Van Den Bemd G-JCM, Stijnen T, Hovius SER (2004) Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen 12:11–17
Orgill DP, Manders EK, Sumpio BE, Lee RC, Attinger CE, Gurtner GC, Ehrlich HP (2009) The mechanisms of action of vacuum assisted closure: more to learn. Surgery 146:40–51
Saxena V, Hwang C-W, Huang S, Eichbaum Q, Ingber D, Orgill DP (2004) Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg 114:1086–1096
Ingber DE (2004) The mechanochemical basis of cell and tissue regulation. Mech Chem Biosyst 1:53–68
Timmers MS, Le Cessie S, Banwell P, Jukema GN (2005) The effects of varying degrees of pressure delivered by negative-pressure wound therapy on skin perfusion. Ann Plast Surg 55:665–671
Labanaris AP, Polykandriotis E, Horch RE (2009) The effect of vacuum-assisted closure on lymph vessels in chronic wounds. J Plast Reconstr Aesthet Surg 62:1068–1075
Morykwas MJ, Faler BJ, Pearce DJ, Argenta LC (2001) Effects of varying levels of subatmospheric pressure on the rate of granulation tissue formation in experimental wounds in swine. Ann Plast Surg 47:547–551
Venturi ML, Attinger CE, Mesbahi AN, Hess CL, Graw KS (2005) Mechanisms and clinical applications of the vacuum-assisted closure (VAC) Device: a review. Am J Clin Dermatol 6:185–194
Gomoll AH, Lin A, Harris MB (2006) Incisional vacuum-assisted closure therapy. J Orthop Trauma 20:705–709
Karlakki SL, Hamad AK, Whittall C, Graham NM, Banerjee RD, Kuiper JH (2016) Incisional negative pressure wound therapy dressings (iNPWTd) in routine primary hip and knee arthroplasties: a randomised controlled trial. Bone Joint Res 5:328–337
Hyldig N, Birke-Sorensen H, Kruse M, Vinter C, Joergensen JS, Sorensen JA, Mogensen O, Lamont RF, Bille C (2016) Meta-analysis of negative-pressure wound therapy for closed surgical incisions. Br J Surg 103:477–486
Wolvos T (2004) Wound instillation--the next step in negative pressure wound therapy. Lessons learned from initial experiences. Ostomy Wound Manage 50:56
Back DA, Scheuermann-Poley C, Willy C (2013) Recommendations on negative pressure wound therapy with instillation and antimicrobial solutions - when, where and how to use: what does the evidence show? Int Wound J 10(Suppl 1):32–42
KCI. V.A.C. Instill® Therapy System - Frequently Asked Questions 2007. https://www.google.com/?gws_rd=ssl#q=KCI.+V.A.C.+Instill%C2%AE+Therapy+System+-+Frequently+Asked+Questions+2007.+&spf=395. Accessed 19 April 2017
Atiyeh BS, Dibo SA, Hayek SN (2009) Wound cleansing, topical antiseptics and wound healing. Int Wound J 6:420–430
Lineaweaver W, Howard R, Soucy D, McMorris S, Freeman J, Crain C, Robertson J, Rumley T (1985) Topical antimicrobial toxicity. Arch Surg 120:267–270
Gabriel A, Shores J, Heinrich C, Baqai W, Kalina S, Sogioka N, Gupta S (2008) Negative pressure wound therapy with instillation: a pilot study describing a new method for treating infected wounds. Int Wound J 5:399–413
Timmers MS, Graafland N, Bernards AT, Nelissen RGHH, van Dissel JT, Jukema GN (2009) Negative pressure wound treatment with polyvinyl alcohol foam and polyhexanide antiseptic solution instillation in posttraumatic osteomyelitis. Wound Repair Regen 17:278–286
Investigators FLOW, Bhandari M, Jeray KJ, Petrisor BA, Devereaux PJ, Heels-Ansdell D, Schemitsch EH, Anglen J, Della Rocca GJ, Jones C et al (2015) A trial of wound irrigation in the initial management of open fracture wounds. N Engl J Med 373:2629–2641
Anglen JO (2005) Comparison of soap and antibiotic solutions for irrigation of lower-limb open fracture wounds. A prospective, randomized study. J Bone Joint Surg Am 87:1415–1422
Shweiki E, Gallagher KE (2013) Negative pressure wound therapy in acute, contaminated wounds: documenting its safety and efficacy to support current global practice. Int Wound J 10:13–43
Ubbink DT, Westerbos SJ, Nelson EA, Vermeulen HA (2008) systematic review of topical negative pressure therapy for acute and chronic wounds. Br J Surg 95:685–692
Peinemann F, McGauran N, Sauerland S, Lange S (2008) Negative pressure wound therapy: potential publication bias caused by lack of access to unpublished study results data. BMC Med Res Methodol 8:4
Powell ET (2008) The role of negative pressure wound therapy with reticulated open cell foam in the treatment of war wounds. J Orthop Trauma 22:S138–S141
Fang R, Dorlac WC, Flaherty SF, Tuman C, Cain SM, Popey TL, Villard DR, Aydelotte JD, Dunne JR, Anderson AM, Powell ET 4th (2010) Feasibility of negative pressure wound therapy during intercontinental aeromedical evacuation of combat casualties. J Trauma Inj Infect Crit Care 69:S140–S145
Maurya S, Bhandari PS (2016) Negative pressure wound therapy in the management of combat wounds: a critical review. Adv Wound Care 5:379–389
DeFranzo AJ, Argenta LC, Marks MW, Molnar JA, David LR, Webb LX, Ward WG, Teasdall RG (2001) The use of vacuum-assisted closure therapy for the treatment of lower-extremity wounds with exposed bone. Plast Reconstr Surg 108:1184–1191
Leininger BE, Rasmussen TE, Smith DL, Jenkins DH, Coppola C (2006) Experience with wound vac and delayed primary closure of contaminated soft tissue injuries in Iraq. J Trauma Inj Infect Crit Care 61:1207–1211
Helgeson MD, Potter BK, Evans KN, Shawen SB (2007) Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds. J Orthop Trauma 21:394–399
Stannard JP, Robinson JT, Anderson ER, McGwin G, Volgas DA, Alonso JE (2006) Negative pressure wound therapy to treat hematomas and surgical incisions following high-energy trauma. J Trauma Inj Infect Crit Care 60(6):1301
Singer RW, Kellam JF (1995) Open tibial diaphyseal fractures. Results of unreamed locked intramedullary nailing. Clin Orthop Relat Res 315:114–118
Webster J, Scuffham P, Stankiewicz M, Chaboyer WP (2014) Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. In: Webster J (ed) Cochrane database Syst. Rev. John Wiley & Sons, Ltd, Chichester, p CD009261
Putnis S, Khan WS, Wong JM-L (2014) Negative pressure wound therapy - a review of its uses in orthopaedic trauma. Open Orthop J 8:142–147
Stannard JP, Volgas DA, Stewart R, McGwin G, Alonso JE (2009) Negative pressure wound therapy after severe open fractures: a prospective randomized study. J Orthop Trauma 23:552–557
Blum ML, Esser M, Richardson M, Paul E, Rosenfeldt FL (2012) Negative pressure wound therapy reduces deep infection rate in open tibial fractures. J Orthop Trauma 26:499–505
Virani SR, Dahapute AA, Bava SS, Muni SR (2016) Impact of negative pressure wound therapy on open diaphyseal tibial fractures: a prospective randomized trial. J Clin Orthop Trauma 7:256–259
Arti H, Khorami M, Ebrahimi-Nejad V (2016) Comparison of negative pressure wound therapy (NPWT) &conventional wound dressings in the open fracture wounds. Pakistan J Med Sci 32:65–69
Zannis J, Angobaldo J, Marks M, DeFranzo A, David L, Molnar J et al (2009) Comparison of fasciotomy wound closures using traditional dressing changes and the vacuum-assisted closure device. Ann Plast Surg 62:407–409
Kakagia D, Karadimas EJ, Drosos G, Ververidis A, Trypsiannis G, Verettas D (2014) Wound closure of leg fasciotomy: Comparison of vacuum-assisted closure versus shoelace technique. A randomised study. Injury 45:890–893
Stannard JP, Volgas DA, McGwin G, Stewart RL, Obremskey W, Moore T, Anglen JO (2012) Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma 26:37–42
Nordmeyer M, Pauser J, Biber R, Jantsch J, Lehrl S, Kopschina C, Rapke C, Bail HJ, Forst R, Brem MH (2016) Negative pressure wound therapy for seroma prevention and surgical incision treatment in spinal fracture care. Int Wound J 13:1176–1179
Pauser J, Nordmeyer M, Biber R, Jantsch J, Kopschina C, Bail HJ, Brem MH (2016) Incisional negative pressure wound therapy after hemiarthroplasty for femoral neck fractures - reduction of wound complications. Int Wound J 13:663–667
Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M (2005) Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 87:1487–1497
Lamagni T (2014) Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother 69:i5–10
Mortazavi SMJ, Schwartzenberger J, Austin MS, Purtill JJ, Parvizi J (2010) Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res 468:2052–2059
Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466:1710–1715
Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE (2007) Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89:33–38
Howell RD, Hadley S, Strauss E, Pelham FR (2011) Blister formation with negative pressure dressings after total knee arthroplasty. Curr Orthop Pract 22:176–179
Pachowsky M, Gusinde J, Klein A, Lehrl S, Schulz-Drost S, Schlechtweg P, Pauser J, Gelse K, Brem MH (2012) Negative pressure wound therapy to prevent seromas and treat surgical incisions after total hip arthroplasty. Int Orthop 36:719–722
Manoharan V, Grant AL, Harris AC, Hazratwala K, Wilkinson MPR, McEwen PJC (2016) Closed incision negative pressure wound therapy vs conventional dry dressings after primary knee arthroplasty: a randomized controlled study. J Arthroplast 31:2487–2494
Gillespie BM, Rickard CM, Thalib L, Kang E, Finigan T, Homer A, Lonie G, Pitchford D, Chaboyer W (2015) Use of negative-pressure wound dressings to prevent surgical site complications after primary hip arthroplasty. Surg Innov 22:488–495
Cooper HJ, Bas MA (2016) Closed-incision negative-pressure therapy versus antimicrobial dressings after revision hip and knee surgery: a comparative study. J Arthroplast 31:1047–1052
Hansen E, Durinka JB, Costanzo JA, Austin MS, Deirmengian GK (2013) Negative pressure wound therapy is associated with resolution of incisional drainage in most wounds after hip arthroplasty. Clin Orthop Relat Res 471:3230–3236
Jaberi FM, Parvizi J, Haytmanek CT, Joshi A, Purtill J (2008) Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty. Clin Orthop Relat Res 466:1368–1371
Lehner B, Fleischmann W, Becker R, Jukema GN (2011) First experiences with negative pressure wound therapy and instillation in the treatment of infected orthopaedic implants: a clinical observational study. Int Orthop 35:1415–1420
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30
Siegel RL, Miller KD, Jemal A (2011) Cancer statistics, 2015. CA Cancer J Clin 65:5–29
Hui JYC (2016) Epidemiology and etiology of sarcomas. Surg Clin North Am 96:901–914
Goodnight JE, Bargar WL, Voegeli T, Blaisdell FW (1985) Limb-sparing surgery for extremity sarcomas after preoperative intraarterial doxorubicin and radiation therapy. Am J Surg 150:109–113
Abramson DL, Orgill DP, Singer S, Gibstein LA, Pribaz JJ (1997) Single-stage, multimodality treatment of soft-tissue sarcoma of the extremity. Ann Plast Surg 39:454–460
Morton DL, Eilber FR, Townsend CM, Grant TT, Mirra J, Weisenburger TH (1976) Limb salvage from a multidisciplinary treatment approach for skeletal and soft tissue sarcomas of the extremity. Ann Surg 184:268–278
Refaat Y, Gunnoe J, Hornicek FJ, Mankin HJ (2002) Comparison of quality of life after amputation or limb salvage. Clin Orthop Relat Res 397:298–305
Aksnes LH, Bauer HCF, Jebsen NL, Follerås G, Allert C, Haugen GS, Hall KS (2008) Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br 90:786–794
Davis AM, Devlin M, Griffin AM, Wunder JS, Bell RS (1999) Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study. Arch Phys Med Rehabil 80:615–618
Bell RS, O’Sullivan B, Liu FF, Powell J, Langer F, Fornasier VL, Cummings B, Miceli PN, Hawkins N, Quirt I et al (1989) The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am 71:370–375
Imparato AM, Roses DF, Francis KC, Lewis MM (1978) Major vascular reconstruction for limb salvage in patients with soft tissue and skeletal sarcomas of the extremities. Surg Gynecol Obstet 147:891–896
Nakasone S, Takao M, Sakai T, Nishii T, Sugano N (2013) Does the extent of osteonecrosis affect the survival of hip resurfacing? Clin Orthop Relat Res 471:1926–1934
Peat BG, Bell RS, Davis A, O’Sullivan B, Mahoney J, Manktelow RT, Bowen V, Catton C, Fornasier VL, Langer F (1994) Wound-healing complications after soft-tissue sarcoma surgery. Plast Reconstr Surg 93:980–987
Kneisl JS, Ferguson C, Robinson M, Crimaldi A, Ahrens W, Symanowski J, Bates M, Ersek JL, Livingston M, Patt J, Kim ES (2017) The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long-term community-based cancer center experience. Cancer Med 6:516–525
Geller DS, Hornicek FJ, Mankin HJ, Raskin KA (2007) Soft tissue sarcoma resection volume associated with wound-healing complications. Clin Orthop Relat Res 459:182–185
Siegel HJ (2014) Management of open wounds. lessons from orthopedic oncology. Orthop Clin North Am 45:99–107
Bujko K, Suit HD, Springfield DS, Convery K (1993) Wound healing after preoperative radiation for sarcoma of soft tissues. Surg Gynecol Obstet 176:124–134
Kunisada T, Ngan SY, Powell G, Choong PFM (2002) Wound complications following pre-operative radiotherapy for soft tissue sarcoma. Eur J Surg Oncol 28:75–79
Bickels J, Kollender Y, Wittig JC, Cohen N, Meller I, Malawer MM (2005) Vacuum-assisted wound closure after resection of musculoskeletal tumors. Clin Orthop Relat Res 441:346–350
Siegel HJ, Herrera DF, Gay J (2014) Silver negative pressure dressing with vacuum-assisted closure of massive pelvic and extremity wounds. Clin Orthop Relat Res 472:830–835
Armstrong DG, Lavery LA, Diabetic Foot Study Consortium (2005) Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366(9498):1704–1710
Blume PA, Walters J, Payne W, Ayala J, Lantis J (2008) Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: A multicenter randomized controlled trial. Diabetes Care 31:631–636
Vuerstaek JDD, Vainas T, Wuite J, Nelemans P, Neumann MHA, Veraart JCJM (2006) State-of-the-art treatment of chronic leg ulcers: a randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg 44:1029–1037
Dumville JC, Webster J, Evans D, Land L (2015) Negative pressure wound therapy for treating pressure ulcers. Cochrane Database Syst Rev 7:CD011334
Forster R, Pagnamenta F (2015) Dressings and topical agents for arterial leg ulcers. Cochrane Database Syst Rev 6:CD001836
Hopf HW, Ueno C, Aslam R, Burnand K, Fife C, Grant L, Holloway A, Iafrati MD, Mani R, Misare B, Rosen N, Shapshak D, Benjamin Slade J Jr, West J, Barbul A (2006) Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen 14:693–710
Webster J, Scuffham P, Sherriff KL, Stankiewicz M, Chaboyer WP (2012) Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev 10:CD009261
Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ (2002) The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg 124:136–145
Damiani G, Pinnarelli L, Sommella L, Tocco MP, Marvulli M, Magrini P, Ricciardi W (2011) Vacuum-assisted closure therapy for patients with infected sternal wounds: a meta-analysis of current evidence. J Plast Reconstr Aesthet Surg 64:1119–1123
Vaez-zadeh S (2011) In response to blister formation with negative pressure dressings. Curr Orthop Pract 22:591
Capewell S, Reynolds S, Shuttleworth D, Edwards C, Finlay AY (1990) Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ 300(6739):1548–1551
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ (2006) Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54:1-15-8
Philbeck TE, Whittington KT, Millsap MH, Briones RB, Wight DG, Schroeder WJ (1999) The clinical and cost effectiveness of externally applied negative pressure wound therapy in the treatment of wounds in home healthcare Medicare patients. Ostomy Wound Manage 45:41–50
De Vries FE, Wallert ED, Solomkin JS, Allegranzi B, Egger M, Dellinger EP, Boermeester MA (2016) A systematic review and meta-analysis including GRADE qualification of the risk of surgical site infections after prophylactic negative pressure wound therapy compared with conventional dressings in clean and contaminated surgery. Medicine (Baltimore) 95:e4673
Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J (2012) Economic burden of periprosthetic joint infection in the United States. J Arthroplast 27(8 Suppl):61–65
Gage MJ, Yoon RS, Gaines RJ, Dunbar RP, Egol KA, Liporace FA (2016) Dead space management after orthopaedic trauma. J Orthop Trauma 30:64–70
Nguyen TQ, Franczyk M, Lee JC, Greives MR, O’Connor A, Gottlieb LJ (2015) Prospective randomized controlled trial comparing two methods of securing skin grafts using negative pressure wound therapy. J Burn Care Res 36:324–328
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
George, J. et al. (2017). Negative-Pressure Wound Therapy: Principles and Usage in Orthopedic Surgery. In: Shiffman, M., Low, M. (eds) Pressure Injury, Diabetes and Negative Pressure Wound Therapy. Recent Clinical Techniques, Results, and Research in Wounds, vol 3. Springer, Cham. https://doi.org/10.1007/15695_2017_53
Download citation
DOI: https://doi.org/10.1007/15695_2017_53
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10700-0
Online ISBN: 978-3-030-10701-7
eBook Packages: MedicineMedicine (R0)